The Latest
-
Masimo COO says he’ll resign if CEO Kiani is forced out
Activist investor Politan Capital Management is attempting to remove longtime Masimo leader Joe Kiani, claiming the company lacks independent oversight.
-
Medtech M&A may pick up after mixed start to 2024: analysts
The annual number of medtech acquisitions is on course to slump to its lowest level since 2017, according to Needham.
-
Philips BiPAP recall now linked to 65 deaths, 952 injuries
Philips began the recall of V30, A30 and A40 machines in March due to an alarm that can interrupt treatment.
Updated June 28, 2024 -
Dexcom to lay off 535 employees in California
A company spokesperson said Dexcom is centralizing its U.S. manufacturing operations in Arizona and repurposing its San Diego facility.
-
FDA shares draft guidance on clinical trial diversity action plans
The agency said which trials need diversity action plans and presented the timeline for implementing the requirement.
-
Cepheid wins FDA nod for fingerstick hepatitis C test
Patients could be diagnosed and potentially receive treatment at the same healthcare visit.
-
Baxter recalls ventilation systems for charging malfunctions
This comes a year after the healthcare company recalled the Life2000 Ventilation System due to oxygen desaturation risks.
-
FDA partners with Gates Foundation to support breath-based diagnostic development
Through a $1.9 million Gates Foundation grant, the collaborators will create methods to help developers make tests that can easily be deployed to rural and remote areas.
-
Medtronic CFO Karen Parkhill leaving for HP
Truist analysts wrote that “there could be some investor angst until a permanent successor is announced.”
-
Abbott and Dexcom are launching the first over-the-counter CGMs. Here are 7 questions on the new tech.
Experts expect the release of new over-the-counter glucose monitors in the U.S. to fuel more widespread use of the devices.
-
Beyond Air cut more than 20% of employees
BTIG analysts said the company’s near-term cash needs, “disappointing sales results and lack of progress on profitability metrics” are concerning.
-
Zimvie mulls sale after takeover approaches: Bloomberg
Zimvie is reportedly working with an adviser to assess its options after strategic investors and industry players showed interest in a deal.
-
Illumina completes Grail spinoff
Nearly four years after Illumina announced a deal to buy Grail, the liquid biopsy maker will debut on Nasdaq Tuesday as a standalone company.
-
Embecta touts its insulin patch pump at ADA
Embecta said its device, with a larger insulin reservoir, addresses an unmet need for people with Type 2 diabetes.
-
Senseonics tips 365-day CGM to double 2025 sales
Senseonics is in talks with insulin pump manufacturers about integrating its implantable Eversense continuous glucose monitor with their devices.
-
Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes
At the American Diabetes Association meeting, Insulet shared study results showing improvements in blood glucose and quality of life.
-
Cardinal Health recalls procedure kits over plastic syringes made in China
Cardinal listed more than 500 catalog numbers in its recall notice and told customers to remove and discard the syringes.
-
Orthofix’s president of global orthopedics resigns
Kimberley Elting will end her eight-year stint at the company in July, continuing Orthofix's recent trend of executive turnover.
-
Tandem names Jean-Claude Kyrillos as chief operating officer
The appointment gives Kyrillos a leading role in work to expand the insulin delivery company’s global operations and achieve profitable growth.
-
Philips Respironics to end manufacturing at two Pennsylvania plants: report
Philips said it would transition operations from the two sites to a third-party manufacturer. The plan will cut 300 jobs, according to the Pittsburgh Post-Gazette.
-
J&J creates open digital platform for surgical applications
J&J at first will focus on surgical video, telepresence and planning and limit access to select hospitals. It plans to make the platform more widely available in 2025.
-
Q&A
ONC’s Micky Tripathi on laying the digital floor for healthcare AI
The agency head discussed ONC’s accomplishments over the past two decades, artificial intelligence opportunities and improving the documentation burden among clinicians.
-
Former Stimwave CEO gets 6 years in prison for fake device scheme
The case centered on allegations that Stimwave marketed a dummy piece of plastic as a receiver of radiofrequency energy.
-
Dermtech files for Chapter 11, lays off 20% of staff
The diagnostic test maker will continue to hunt for a buyer for its skin cancer detection patch.
-
Globus Medical gets FDA nod for ortho robot
With the clearance, Globus could gain share in the roughly $15 billion market for reconstructive orthopedic surgery, RBC Capital Markets analyst Shagun Singh said.